Showing results (1281-1290 of 1,858) with videos related to
Sort By:
Pageof 186
Clinical Medicine Insights. Oncology|June 23, 2010
A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second ReportYasushi Rino, Norio Yukawa, Hitoshi Murakami, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|October 1, 1995
[Empyema caused by perforation of metastatic colon cancer: a case report]N Ishiwa, T Maehara, T Morohoshi, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 24, 2004
Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter studyHideki Kawanishi, Yoshindo Kawaguchi, Hiroyoshi Fukui, et al.Modern Rheumatology Case Reports|February 9, 2021
Effectiveness of subcutaneous tocilizumab in refractory adult Still's disease: report of three cases and a review of the literatureMasataka Torigoe, Keisuke Maeshima, Yuhei Kuriyama, et al.The Prostate|April 15, 2014
Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancerMasaki Shiota, Momoe Itsumi, Akira Yokomizo, et al.The Prostate|April 18, 2014
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancerMasaki Shiota, Akira Yokomizo, Ario Takeuchi, et al.Journal of Medical Case Reports|October 16, 2009
Chest wall resection and reconstruction using titanium micromesh covered with Marlex mesh for metastatic follicular thyroid carcinoma: a case reportNobuyasu Suganuma, Nobuyuki Wada, Hiromasa Arai, et al.Cancer Letters|September 21, 2005
Water-generated negative air ions activate NK cell and inhibit carcinogenesis in miceRoppei Yamada, Syunsuke Yanoma, Makoto Akaike, et al.Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|March 1, 2005
[Treatment of bedsores--combination of therapies depended the experimental design method]Hiroko Miyaji, Hirofumi Sakurai, Masayuki Kikawada, et al.Biochemical and Biophysical Research Communications|May 16, 1994
Cyclic hexapeptide endothelin receptor antagonists highly potent for both receptor subtypes ETA and ETBT Kikuchi, T Ohtaki, A Kawata, et al.Pageof 186